FORMULATION & DEVELOPMENT OF PELLETS OF TOLTERODINE TARTRATE: A QUALITATIVE STUDY ON WURSTER BASED FLUIDIZED BED COATING TECHNOLOGY by Gautam, Namrata & Trivedi, Piyush
Namrata et al                                 Journal of Drug Delivery & Therapeutics; 2012, 2(4), 90-96    90 
 
© 2011, JDDT. All Rights Reserved                                                         ISSN: 2250-1177                                                    CODEN (USA): JDDTAO 
Available online at http://jddtonline.info 
RESEARCH ARTICLE 
FORMULATION & DEVELOPMENT OF PELLETS OF TOLTERODINE TARTRATE: A 
QUALITATIVE STUDY ON WURSTER BASED FLUIDIZED BED COATING 
TECHNOLOGY 
*Gautam Namrata, Trivedi Piyush 
School of Pharmaceutical Sciences, Rajiv Gandhi Technical University, Gandhi Nagar, Bhopal (MP) – 462033 India 
*Corresponding Author’s Email: namratapharma@gmail.com 
Received 07 June 2012; Review Completed 05 July 2012; Accepted 05 July 20122012, Available online 15 July 2012 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION: 
Pellets are agglomerates of fine powders or granules of 
bulk drugs and excipients. They consist of small, free-
flowing, spherical or semi-spherical solid units, typically  
from about 0.5 mm to 1.5 mm and are intended usually for 
oral admin istration
 1
. Pellets offer a great flexib ility in  
pharmaceutical solid dosage form design and development. 
They flow freely and pack easily without significant 
difficult ies, resulting in uniform and reproducible fill 
weight of capsules and tablets
 2
. Successful film coating 
can be applied onto pellets due to their ideal spherical 
shape and low surface area-to-volume ratio. Available 
techniques for manufacturing of pelletized mult iparticulate 
systems are: 
 Wurster process (solution or suspension layering).  
 Extrusion spheronization  
 Powder layering  
In a study on chronotherapy of rheumatoid arthritis by 
Akhgari etal 
3
, the effect of varying the ratios of Eudragit  
L100 and Eudragit S100 on release of coated pellets of 
indomethacin was evaluated along with the effect of coat 
thickness using a statistical approach. The major 
mechanis m by which the drug is released from pellets  
depends on the type of coating; insoluble coating, pH-
dependent coating (whose solubility changes dramatically  
at some location in GI tract) and slowly erodible coating 
4.
 
The method of application and processing conditions may 
influence the porosity of the coating and consequently the 
release mechanism. 
 Bottom-Spray Coating 
5
: This processing option uses the 
energies and controls of the Wurster to create a pneumatic 
mass transport inside a special insert which consists of a 
perforated bottom screen with defined free areas. Most of 
the process air is channeled through the center via a tube as 
such producing a venture effect, which sucks the product 
from outside the partition past the spray nozzle. Leav ing 
the cylindrical partit ion and entering the conical expansion 
chamber the part icle velocity is dramatically reduced, 
excess moisture is rapidly evaporated with the dry product 
returning again and again through the coating zone to 
receive more coating material. Th is uniform statistical 
residence time of all particles in the coating zone results in 
a very homogenous coating. Due to the high kinetic energy 
provided by the pneumatic mass flow moist particles are 
separated as such allowing the individual coating of 
even very small particles. Due to the nozzle being 
positioned directly inside the product and concurrently 
spraying, a premature viscosity change of the coating 
droplet is avoided. A layer of coating does not occur 
during a single pass through the coating zone, but relies on 
many such passes to produce complete coverage of the 
surface. Droplet formation, contact, spreading, coalescence 
and evaporation are occurring almost simultaneously 
during the process. The nozzles typically used in the 
flu idized bed coating process are binary: liquid is supplied 
at a low pressure and is sheared into droplets by air. 
Droplet size and distribution are more controllable with 
this type of nozzle than with a hydraulic nozzle, especially  
at low liquid flow rates. However, the air used for 
atomizat ion also contributes to evaporation of the coating 
solvent. This evaporation results in increasing the droplet’s 
viscosity and it may inh ibit spreading and coalescence 
upon contact with the core material. Another factor 
affecting droplet viscosity is the distance that the droplets 
travel through the primary evaporation media (the 
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flu idization air) before impinging on the core. This 
problem is amplified with the use of organic solvents 
which evaporate much more quickly than water. In all 
three process techniques, the nozzle is positioned to 
minimize d roplet travel distance. The most significant 
process variable is the selection of technique to be used. 
The majority of the process & formulat ion variables 
effecting the film formation are listed below
 6
.  
Process variables: 
1. Evaporation 
a) Fluidization air volume 
b) Fluidization air temperature 
c) Fluidization air humidity 
2. Application Rate. 
a) Solution concentration 
b) Coating Zone 
3. Droplet Size 
Formulation variables: 
a) Coating thickness 
b) Particle size of final dosage form. 
c) Desired Surface characteristics 
 
The objective of the present study was to study the 
applicability of Wurster coating technology for making 
sustained-release pellets in a three-step process: (a) seal 
coating of N.P.S (b) loading of drug by suspension 
layering onto seal coated nonpareil seeds and (b) 
subsequent film coating of drug-loaded pellets with ethyl 
cellu lose polymer dispersion in the same equipment. 
MATERIALS AND METHODS: 
Materials:  
Sugar pellets (Nu-pareil, Hanns Werner, Tornesch, 
Germany) of size fract ions 25-30# were used as the cores 
for coating. Seal coat solution included, ethylcellulose 
(was obtained from Dow Chemical Company, Midland, 
USA) and PVPK30 (was obtained from BASF 
Corporation, USA). Drug layering suspension consisted of 
Tolterodine Tartrate, (obtained from Ranbaxy Dewas) was 
of USP grade and hypromellose (Methocel-E5, Colorcon, 
NJ, USA). Finally extended release coating of polymer 
was done using aq. dispersion of ethylcellulose 
(Surelease@, Colorcon, West Point, PA).  
Method: 
Dummy batches of seal coated pellets, drug layered pellets 
& E.R coated pellets were prepared to optimize the 
formulat ion as well as process variables of Wurster 
processor. Nonpareil seeds were loaded and seal coating 
(ethylcelluose) was performed fo llowed by drying and 
sifting. Further the seal coated pellets were divided into 
batches and binder concentration was optimized in the 
drug layer using methocel (HPMC E5) as binder. Finally  
the dried and sifted drug layered pellets were div ided into 
groups to optimize the percent weight buildup of extended 
release polymer SURELEASE to obtain the desired 
dissolution profile. 
RES ULTS & DISCUSSION: 
The drug was found to be compatible with excipients by 
D.S.C. During formulation and optimization of seal 
coating, drug layering and E.R coating, various format ion 
and process variables were studied for Wurster based fluid 
bed coating technology. Finally the optimized  batch of E.R 
coated pellets was evaluated for drug content, particle size 
distribution and surface morphology (SEM analysis) and 
Invitro dissolution study.  
To evaluate the possible interaction between the drug and 
polymers, thermal analysis was performed by differential 
scanning calorimetry. The DSC curve of the pure drug 
showed a single endothermic peak at 210.5
o
C (Fig.1), 
corresponding to the melt ing of the drug (205
0
C-210
0
C). In  
the physical mixture of drug and excipients, endothermic 
peak for drug was still observed at 206.84
o
C (Fig.2). The 
analysis of thermo grams revealed no physical interaction 
between the polymer and the drug. 
 
                
Figure 1: DSC thermogram of pure drug                                     Figure 2: D.S.C Thermogram of Drug Excip ients Mixture  
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SEAL COATING: 
Due to high solubility, the sugar spheres immediately get 
dissolved in aqueous media without build up of sufficient 
osmotic pressure in the core. In order to retard the 
dissolution rate of non-pariel seeds, a film of water 
insoluble ethyl cellu lose (8-12% wt/wt) is applied on non-
pariel seeds. Before seal coating of nonpareil seeds, 
dummy batches were prepared to optimize the formulat ion 
variables as well as process variables for seal coat 
(Table.1). The formulation variable chosen was the 
strength of seal coat solution (organic).Upon increasing the 
strength of coating solution, it was found that nozzles of 
Wurster column get blocked due to higher viscosity 
(because of evaporation of organic solvent inside the 
column). Hence the conc. of seal coat solution was 
selected as 4% randomly.  The seal coated pellets were 
evaluated for % weight build-up and % weight of fines 
generated. The results (Table.2) show that nonpareil seeds 
were coated to their desired weight build-up (9-10%) with 
fines within the range of their limits (2-5%). To avoid the 
generation of electrostatic charges over nonpareil seeds in 
Wurster column, small quantity of talc was added 
intermittently.  
Table 1: Process parameters of seal coating (Dummy trial 1) 
 
Table 2: Evaluation of seal coated pellets for % weight build-up and % fines 
Batch No. %  Wt. Build-up(wt/wt) %  Fines 
FB1 9.499% 2.73% 
FB2 9.964% 1.79% 
FB3 10.163% 2.96% 
DRUG LAYERING: 
Drug layering was performed by coating aqueous 
suspension of drug over seal coated pellets. Binder conc. 
was selected as formulation variab le to be optimized in  
drug layer to achieve proper film formation and minimize 
the production of fines during coating.Seal coated pellets 
were further coated with drug layering suspension up to 
the desired weight buildup having the same conc. of drug 
but variable binder conc. (1.5%, 2.5% and 4 %) in  drug 
layer. 
At 1.5% binder concentration, the suspension might be so 
diluted that the solid particles deposited loosely on the 
substrate surface, resulting in low granule density, high 
porosity and large pore size. As the binder concentration 
was increased to 2.5% and 4% successively, the solid 
particles adhered tightly to the substrate surface. Thus the 
granule density was increased and the porosity and pore 
size were decreased. Owing to tight binding of the solid  
particles from the concentrated suspension to the surface 
of nonpareil seeds, the pellet surface appeared to be 
smoother than those prepared at lower binder 
concentrations. Process variables were optimized by 
dummy batches (Table.3) then finally selected parameters 
were set for drug layering. 
Drug layered pellets were evaluated for assay, drug release 
profile and amount of fines generated, according to which 
binder concentration in drug layer was selected. Assay 
results of drug layered pellets indicate the desired drug 
content (99 to100%) and content uniformity in all batches 
besides different conc. of binder in each batch. The 
dissolution of every uncoated batch was found to be 
complete with in 20 min. The results are depicted in Fig.3. 
However it was observed that lower binder concentration 
resulted in slightly faster in itial dissolution.  
Weight loss in form of fines was also recorded for final 
selection of binder conc. in drug layer which was found be 
minimum and within limits (2.1%) in FD3. Due to high 
drug content, uniform drug release profile, good 
appearance and less fine generation, formulation batch 
FD3 (4% HPMC) was chosen for further coating with 
extended release polymer. 
Table 3: Process parameters of drug layering (Dummy trial): 
Time 
 
(hrs) 
Pump 
speed 
(rpm) 
Spray 
rate 
g/min 
Blower 
speed 
(rpm) 
Nozzle 
press. 
(pas) 
Atom. 
press. 
(bar) 
Diff. 
press.  
(mbar) 
Bed 
temp 
(
o
C) 
R.H 
 
% 
Inlet 
Temp 
(
o
C) 
Outlet 
Temp 
(
o
C) 
0-1 11 64 4.2 2 1.3 5 25 32.6 39 32 
1-2 17 100 5.7 2 1.3 4.9 26 32.6 42 33 
2-4 17 100 5.7 2 1.3 4.9 26 32.5 30 29 
4-6 17 100 5.7 2 1.3 4.9 26 32.4 44 33 
6-7 17 100 5.7 2 1.3 4.9 26 32.4 29 28 
7-8 18 106 5.9 2 1.3 4.9 26 32.4 41 33 
Time 
(hrs) 
Pump 
speed 
(rpm) 
Spray rate 
(g/min) 
Blower 
speed 
(rpm) 
Nozzle 
press. 
(pas) 
Atom.  
press. 
(bar) 
Diff. 
Press.  
mbar 
Bed 
temp. 
(oC) 
R.H   
(%) 
Inlet 
temp 
(oC) 
Outlet 
temp 
(oC) 
0-1 6 35.2 4.8 2 2.5 4.8 38 32.7 54 37 
1-2 7 41.1 4.5 2 2.5 4.8 38 32.8 52 37 
2-3 6 35.2 4.5 2 2.5 4.8 38 32.7 57 42 
3-4 8 47.05 4.7 2 2.5 4.9 38 32.5 55 39 
4-5 10 58.8 5.3 2 2.5 4.9 38 32.5 56 40 
5-6 10 58.8 5.4 2 2.5 4.9 38 32.5 52 39 
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Figure 3: In-vitro release profile of drug layered beads 
(different conc. of binder in 3 batches) 
SURELEAS E COATING: 
Aqueous dispersion of ethyl cellulose (SURELEASE 25%) 
was diluted to 15% to coat over drug layered beads along 
with hypromellose as binder in coating solution & 
formulat ion variable selected was % weight buildup (% 
coating) of extended release polymer. To optimize % 
coating of extended release polymer, three formulations, 
FS1, FS2 and FS3 with different levels of polymeric 
coating (6.5% w/w, 7.5% w/w and 8.5%w/w respectively) 
were manufactured and analyzed for desired drug release 
profile compared to innovator’s product. Drug release 
from the coated pellets depends on the uniformity of the 
coating. The success of any coating process is based on the 
uniformity of coating on the pellets within a batch and 
reproducibility from batch to batch. When coating is based 
on weight gain, the thickness of the membrane is 
controlled by the surface area of the pellets on which the 
coating is applied.  
Drug release through ethyl cellulose membrane is expected 
to occur by diffusion through the membrane and the micro-
pores in the membrane. Therefore, drug release depends on 
the thickness and the porosity of the membrane. Increasing 
the level of ethyl cellu lose coating, the mean pore d iameter 
and the porosity decreased and the pore size d istribution 
shifted toward smaller pores. In a comparative study of 
different coating levels of ethyl cellulose, drug release was 
presumed to be mediated via the tortuous matrix o f the 
polymer layer at 2-10% coating wh ile at levels from 12-
20%, the release occurred by diffusion through the 
polymer film. At intermediate levels of 11-12%, both 
mechanis ms are operative. Thus drug release occurs via 
the tortuosity of the drug-binder layer and concentration 
gradient across the polymer film. 
Process variables such as spray rate, droplet size, bed 
temperature, spray mode and so forth can strongly 
influence the drug release. The coating temperature should 
be sufficiently high to achieve efficient water removal and 
subsequent particle coalescence. In general, it should be 
10°C to 20°C h igher than the manufacturing temperature 
of the polymer d ispersion. Generally it has been seen that 
drug release with Surelease-coated pellets decreases on 
increasing the product temperature from 32°C to 48°C 
because of more complete film format ion. However, an  
excessively high inlet temperature can potentially cause 
difficult ies in processing such as electrostatic interactions 
and agglomeration of the beads because of excessive 
drying or softening and sticking of the coating. Process 
variables were optimized by dummy batches (table 4). E.R 
coated pellets were evaluated for dissolution profile, 
micromeritic properties (particle size distribution, angle of 
repose, % compressibility index), drug content and 
scanning electron microscopy (final optimized batch). 
Table 4: Process parameters of ER coating (Dummy trial)  
 
Table 5: Final optimized formula for seal -coating, drug -layering & E.R coating of N.P.S 
 
Time  
 
(hrs) 
Pump 
speed 
(rpm) 
Spray 
rate 
(g/min) 
Blower 
speed 
(rpm) 
Nozzle 
press. 
(pas) 
Atom. 
press. 
(bar) 
Diff. 
press. 
(mbar) 
Bed 
temp 
(oC) 
R.H 
(%) 
Inlet 
Temp 
(oC) 
Outlet 
Temp 
(oC) 
0-0.30 9 52.98 5.8 2 2.5 4.8 38 32.7 47 37 
0.30-1 9 52.98 7.9 2 2.5 4.8 3.8 32.8 50 35 
1-1.30 9 52.98 8.2 2 2.5 4.8 3.8 32.7 28 29 
1.30-2 9 52.9 8.9 2 2.5 4.8 3.8 32.9 29 29 
2-2.30 10 58.8 9.3 2 2.5 4.9 3.8 32.9 50 38 
2.30-3 10 58.8 6.8 2 2.5 4.7 3.8 32.8 29 29 
3-3.30 13 76.4 6.8 2 2.5 4.6 3.8 Do 32 32 
3.30-4 15 88.2 6.9 2 2.5 4.7 3.8 33 31 31 
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Table 6: Optimized process variables for different stages of coating 
 
 
 
 
 
 
 
EVALUATION OF E.R COATED PELLETS : 
Quantitative estimation of drug in E.R coated pellets 
and content uniformity: 
Powdered pellets equivalent to 10 mg of drug was 
transferred to 100 ml volumetric flask and made-up the 
volume to the mark with methanol and ultrasonicated for 
10 minutes. The solution was then filtered was further 
diluted with methanol to obtain 40 μg/ml of drug 
solution. The concentration of drug was determined by 
measuring the absorbance of the sample at 284.0 nm in  
zero order spectrum modes. The test was repeated to 
check the content uniformity. An assay result of ER 
coated pellets was found to be uniform among all batches 
and lies in pharmacopoeial limits (95 % to 105%) besides 
different thickness of polymeric layer in each batch 
(Table.7). 
Table 7: Drug content (assay) of ER coated pellets  
Batches    
Assay 
FS1                          
(% ) 
FS2               
(% ) 
FS3                  
(%  ) 
1. 99.91 98.20 99.83 
2. 99.79 99.29 97.87 
3. 99.45 98.62 99.12 
Average: 99.71 99.03 98.94 
Std. Dev. ± 0.238607 ± 0.549758 ± 0.992321 
Characterization for Micromeritic Properties: 
Particle size distribution: Upon sieve analysis, ER 
coated pellets showed a random size distridution (Fig.4). 
85-90% of particles were found to be greater than 22 
mesh and are about 710-850 µm in size. Opt imum 
particle size distribution was obtained in all the three 
batches, which resulted in good flow properties. 
 
Figure 4: Particle size distribution of E.R coated pellets  
Physical Characterization: 
E.R coated pellets were evaluated for angle o f repose, 
compressibility index and Hausner’s ratio. The results 
(Table.8) indicated that values of angle of repose and 
compressibility index for all three batches (lies b/w 20-
25
0 
and 5-15% respectively) shows the good flow 
property of pellets. 
Table 8: Characterization of pellets for their physical 
properties 
 
In-vitro Dissolution Study of E.R Coated Pellets . 
In-vitro dissolution study was performed in both 
phosphate buffer (pH 6.8) as well as in simulated gastric 
flu id to estimate the release of drug at various sites of 
gastrointestinal tract and to determine the maximum 
absorption site. The different formulat ions prepared by 
changing the process variables were subjected to invitro 
drug release studies. 
Weighed and placed E.R coated pellets equivalent to 4 
mg of drug (based on theoretical claim) into each of three 
dissolution vessels (USP TYPE 1) and emptied contents 
of one capsule of marketed formulat ion (innovator’s 
product) into fourth dissolution vessel and started the 
dissolution at 100 rpm. At specified time intervals 
samples were withdrawn. Filtered the solution and 
measured the absorbance of samples at λmax 281.5 to 
determine the % cumulative drug release. 
 
Figure 5: Comparative invitro release profile of ER 
coated pellets w.r.t marketed fo rmulat ion (M.F) in 
phosphate buffer (pH 6.8) 
Process Variables Coating stages of E.R coated pellets  
Seal Coating Drug Layering  ER Coating  
Inlet air temperature (
0
C) 38-42°C 53-57°C 37-43°C 
Product bed temperature  (
0
C) 33-37°C 40-46°C 33-37°C 
Atomization air p ressure (bar) 1.2-3 1.2-3 1.2-3 
Relative humid ity (%) 32-33% 32-33% 32-33% 
Blower speed  (rpm) 3-7 4-7 5-10 
Spray rate (g/min) 35-50 35-60 50-90 
Batch No. 
Parameters 
FS1 FS2 FS3 
Angle of repose (°) 21 23.4 21.4 
Bulk density (g/cm3) 0.54 0.63 0.47 
Tapped density (g/cm3) 0.625 0.74 0.57 
Compressibility Index (%) 13.6 14.8 17.5 
Hausner’s ratio 1.15 1.17 1.22 
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Figure 6: Comparative invitro release profile of ER coated 
pellets w.r.t marketed formulat ion (M.F) in s imulated 
gastric fluid (pH 1.2) 
Surface Morphology and Scanning Electron 
Microscopy: 
The surface characteristics of the pellets were observed by 
SEM using a scanning electron microscope.  
  
Figure 7: Photomicrograph of ER coated pellet       
            
Figure 8: Cross-sectional SEM image of ER coated pellets  
Scanning Electron Microscopy (SEM) was performed  
using (JEOLJSM–6380LA) Analytical Scanning Electron 
Microscope. Pellets were deposited on carbon conductive 
2.5 mm double sided tape and dusted to remove the excess. 
The samples were imaged using 5-15 KV electron beam. 
Also the cross sectional images were captured to indentify 
the drug layer and polymer layer separately. 
Data Interpretation by Kinetic Models 
[8-11]
  
In order to investigate the release mechanism, the data was 
fitted to models representing Zero-order, First-order, 
Higuchi’s square root of time, Kors meyer’s Peppas model 
and Hixson Crowell model o f drug release. 
The data was processed for regression analysis and 
interpretation of data was based on the value of resulting 
correlation coefficients. Higher value of correlat ion 
coefficient was obtained in case of Hixson Crowell model. 
It can be concluded that ficikian diffusion was the 
predominant mechanis m of drug release. 
 
                                                           
    
Figure 9: Graphs for Kinetic Models of Drug Release Mechanism 
DISCUSS ION: 
The nozzles typically used in the fluidized bed coating 
process are binary: liquid is   supplied at a low pressure 
and is sheared into droplets by air. Droplet size and 
distribution are more controllable with this type of nozzle 
than with a hydraulic nozzle especially at low liquid flow 
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rates. There are several process variables as well as 
formulat ion variables that affect the efficiency of nozzle.  
For instance, usage of organic solvent for coating may lead  
to nozzle blockade due to increased viscosity of solvent 
during processing because of evaporation of solvent. 
Hence aqueous solution is more preferred w.r.t to organic 
solution. Spray rate should not be too high because it may  
lead to deposition of residual solvent at nozzle tip as well 
as sticking of coating sol to filter bags leading to reduced 
m/c efficiency. St rength of coating 
sol/dispersion/suspension plays important role in nozzle 
blockade; hence it should not be highly conc. as well as 
not very much diluted. Particle size of coating material 
should also be optimum. To improve machine efficiency, a 
proper control over atomizing velocity, atomizing 
pressure, fluidizat ion velocity, fluidization volume, inlet  
temperature, temperature of product bed, relative humid ity 
as well as spray rate should be maintained. Filter bags 
should be shaken intermittently at regular intervals to 
remove dust and fines which may result to sticking of 
coating sol over them leading to weight loss from the 
system. Development of static electricity takes place due to 
high flu idization velocity, responsible for h igh shear b/w 
the particles and fines generation. Hence talc is added in 
b/w the process to avoid development of charges over 
particle surface and ult imately reduction of fines.  
CONCLUSION: 
Fluid bed processors offer unique opportunity to develop and 
produce coated controlled release products. However various 
process parameters easily can alter the performance of a product 
and hence should be examined thoroughly during the scale up 
phase. The inter play of various processing parameters presents a 
great challenge in optimizing the coating process, hence it is 
extremely necessary to investigate and understand these variables  
to ensure a reproducible performance of controlled release 
products. 
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